Skip to main content
. 2018 Jan 31;18:117. doi: 10.1186/s12885-018-4011-8

Fig. 1.

Fig. 1

Representative 2-DE serum protein profiles before and after RFA treatment for hepatocellular carcinoma patients. These differentially expressed protein spots (labelled as A1 to A18 and B2 to B14) were subsequently identified by MALDI-TOF MS/MS analyses